Policy / Pricing Makary resigns, with Diamantas named as acting FDA commissioner Pharmaceutical TechnologyThe resignation comes after reports suggested the President was considering firing him.Read full story pharminent May 12, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology The resignation comes after reports suggested the President was considering firing him. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugNext: Isomorphic Labs receives $2.1bn for AI drug development Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
